Jane Street Group LLC boosted its holdings in National Health Investors, Inc. (NYSE:NHI - Free Report) by 68.3% in the third quarter, according to its most recent Form 13F filing with the SEC. The fund owned 60,099 shares of the real estate investment trust's stock after purchasing an additional 24,380 shares during the period. Jane Street Group LLC owned about 0.13% of National Health Investors worth $5,052,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also recently bought and sold shares of NHI. Blue Trust Inc. boosted its holdings in National Health Investors by 2,651.9% in the second quarter. Blue Trust Inc. now owns 743 shares of the real estate investment trust's stock valued at $47,000 after purchasing an additional 716 shares during the last quarter. Sumitomo Mitsui Trust Holdings Inc. lifted its holdings in National Health Investors by 16.0% during the 2nd quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 472,959 shares of the real estate investment trust's stock worth $32,034,000 after buying an additional 65,104 shares during the last quarter. Lee Danner & Bass Inc. bought a new position in National Health Investors during the 2nd quarter worth approximately $5,089,000. International Assets Investment Management LLC bought a new position in National Health Investors during the 2nd quarter worth approximately $36,000. Finally, Van ECK Associates Corp lifted its holdings in shares of National Health Investors by 6.9% in the 2nd quarter. Van ECK Associates Corp now owns 6,404 shares of the real estate investment trust's stock worth $434,000 after purchasing an additional 416 shares during the last quarter. Hedge funds and other institutional investors own 62.51% of the company's stock.
National Health Investors Price Performance
Shares of NHI traded up $0.31 during trading hours on Tuesday, hitting $71.75. The stock had a trading volume of 220,330 shares, compared to its average volume of 199,946. National Health Investors, Inc. has a 52 week low of $51.59 and a 52 week high of $86.13. The company's fifty day moving average is $76.63 and its two-hundred day moving average is $75.61. The company has a debt-to-equity ratio of 0.92, a current ratio of 10.29 and a quick ratio of 10.29. The stock has a market capitalization of $3.26 billion, a price-to-earnings ratio of 24.66, a P/E/G ratio of 4.87 and a beta of 1.04.
National Health Investors (NYSE:NHI - Get Free Report) last announced its quarterly earnings data on Tuesday, November 5th. The real estate investment trust reported $0.65 EPS for the quarter, missing analysts' consensus estimates of $1.07 by ($0.42). National Health Investors had a net margin of 38.53% and a return on equity of 10.11%. The firm had revenue of $63.32 million during the quarter, compared to the consensus estimate of $67.93 million. During the same quarter in the previous year, the business posted $1.08 earnings per share. The firm's quarterly revenue was up 1.7% on a year-over-year basis. On average, analysts anticipate that National Health Investors, Inc. will post 4.42 EPS for the current year.
National Health Investors Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Wednesday, January 29th. Shareholders of record on Tuesday, December 31st will be paid a $0.90 dividend. This represents a $3.60 annualized dividend and a dividend yield of 5.02%. The ex-dividend date of this dividend is Tuesday, December 31st. National Health Investors's dividend payout ratio is 123.71%.
Wall Street Analyst Weigh In
NHI has been the topic of several analyst reports. Bank of America initiated coverage on National Health Investors in a research report on Tuesday, September 24th. They issued a "buy" rating and a $92.00 target price on the stock. Truist Financial increased their price target on National Health Investors from $65.00 to $78.00 and gave the company a "hold" rating in a research report on Friday, August 30th. StockNews.com lowered shares of National Health Investors from a "buy" rating to a "hold" rating in a research note on Tuesday, October 15th. Finally, Wells Fargo & Company downgraded National Health Investors from an "overweight" rating to an "equal weight" rating and upped their target price for the company from $81.00 to $86.00 in a report on Tuesday, October 1st. Three analysts have rated the stock with a hold rating and four have given a buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average price target of $76.33.
View Our Latest Analysis on NHI
National Health Investors Company Profile
(
Free Report)
Incorporated in 1991, National Health Investors, Inc NYSE: NHI is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.
Further Reading
Before you consider National Health Investors, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and National Health Investors wasn't on the list.
While National Health Investors currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link below to learn more about using beta to protect yourself.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.